Strategies to defeat ketamine-induced neonatal brain injury
Christopher P. Turner(Wake Forest University), Aaron A. Phillips(University of Calgary), Elaine Z. Shing(Wake Forest University), Brendan T. Finucane(Wake Forest University), Anna Carnes(Hospital Universitari de Santa Maria), Jae Hwan Kim(Wake Forest University), Chunlei Liu(Qingdao Municipal Hospital), Jenny Chou(Wake Forest University), T. Haddad(Wake Forest University), Lance D. Miller(Genome Institute of Singapore)
Cited by 50
Related Papers
Genetic Reclassification of Histologic Grade Delineates New Clinical Subtypes of Breast Cancer
|Cancer Research|2006|757
Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy
|Journal for ImmunoTherapy of Cancer|2017|239
Neuropsychiatric symptoms and quality of life in Spanish patients with Alzheimer’s disease during the COVID‐19 lockdown
|European Journal of Neurology|2020|215
Sal-like protein 4 (SALL4), a stem cell biomarker in liver cancers
|Hepatology|2012|195